New obesity pills try to shed past problems

Good news, fatsos!

The first of three new fat-fighting pills faces public scrutiny by U.S. regulatory advisers next week, as small biotechs target the growing number of obese Americans despite a checkered past for weight-loss drugs.

You keep popping these things for as long as we do not have to pay for them.

And by the way...

"Obesity is the Cape Hatteras of drug development," Morningstar analyst Damien Conover said, "where all these ships wanted to go and they sunk."

You are likely to experience the same results.

But, as long as we don't have to foot the bill, have a ball.

And another helping.